Quantum Diamond Technologics

Quantum Diamond Technologies is a private, pre-revenue diagnostics company pioneering a novel quantum sensing platform for biomarker detection. Founded in 2016 and based on research from Harvard University, its core technology uses nitrogen vacancy centers in diamond to image magnetic tags, overcoming limitations of optical methods like extensive washing and background interference. The platform promises significant advantages in sensitivity, speed, sample volume, and simplicity, targeting applications in neurology, oncology, infectious diseases, and broader life sciences research. The company has secured non-dilutive grant funding and is actively seeking partnerships for platform development and assay creation.

Quantum sensing platform using nitrogen-vacancy (NV) centers in synthetic diamond to image magnetic nanoparticle tags bound to biomarkers, enabling ultrasensitive, wash-free detection of proteins, nucleic acids, and cells.

QDTI competes with established high-sensitivity immunoassay platforms (e.g., Quanterix Simoa, Meso Scale Discovery) and emerging molecular techniques. Its primary competitive advantage is the all-magnetic, wash-free detection method, which promises superior simplicity, speed, and potentially lower cost per test compared to optical methods requiring extensive sample processing.